Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review

Recent studies have identified an association between perturbed type I interferon (IFN) responses and the severity of coronavirus disease 2019 (COVID-19). IFNα intervention may normalize the dysregulated innate immunity of COVID-19. However, details regarding its utilization and therapeutic evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Ling-Ying, Feng, Po-Hao, Yu, Ming-Sun, Chen, Min-Chi, Lin, Alex Jia-Hong, Chen, Justin L., Yu, Lennex Hsueh-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755267/
https://www.ncbi.nlm.nih.gov/pubmed/35115233
http://dx.doi.org/10.1016/j.cytogfr.2022.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755267/
https://www.ncbi.nlm.nih.gov/pubmed/35115233
http://dx.doi.org/10.1016/j.cytogfr.2022.01.001

Ejemplares similares